Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

75.96 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PTC Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods. 
Via Benzinga
News headline image
14 Analysts Have This to Say About PTC Therapeutics ↗
 
Via Benzinga
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
The Latest Analyst Ratings for PTC Therapeutics ↗
 
Via Benzinga
News headline image
PTC Therapeutics's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
PTC Therapeutics Stock Tumbles: Company Stops Preclinical Gene Therapy Programs After Failed Friedreich's Ataxia Study ↗
 
Via Benzinga
News headline image
Dow Falls Over 100 Points; Analog Devices Posts Upbeat Q2 Earnings ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.44% to 32,908.94 while the NASDAQ fell... 
Via Benzinga
News headline image
Why Is Apexigen (APGN) Stock Up 31% Today? ↗
Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS). 
Via InvestorPlace
News headline image
Why Is Ocugen (OCGN) Stock Down 22% Today? ↗
Ocugen (OCGN) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering for its shares. 
Via InvestorPlace
News headline image
Why Is PTC Therapeutics (PTCT) Stock Down 21% Today? ↗
PTC Therapeutics (PTCT) stock is taking a beating on Wednesday after the company provided investors with an update on a clinical trial. 
Via InvestorPlace
News headline image
Analyst Expectations for PTC Therapeutics's Future ↗
 
Via Benzinga
News headline image
Where PTC Therapeutics Stands With Analysts ↗
 
Via Benzinga
News headline image
Looking Into PTC Therapeutics's Return On Capital Employed ↗
 
Via Benzinga
News headline image
Earnings Outlook For PTC Therapeutics ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday morning! 
Via InvestorPlace
Expert Ratings for PTC Therapeutics ↗
 
Via Benzinga
News headline image
Agilent, PTC Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
PTC Therapeutics Takes Investors On A Ride With A Failed Study, Scrapped Programs, Ousted CFO ↗
PTC announced a barrage of news, starting with a failed Phase 3 study. 
Via Investor's Business Daily
News headline image
Chart Of The Day: PTC Therapeutics ↗
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for patients with rare disorders. 
Via Talk Markets
News headline image
Palo Alto Networks To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Thursday ↗
Needham raised the price target for Dynatrace, Inc. (NYSE: DT) from $52 to $56. Needham analyst James Ricchiuti maintained a Buy rating. Dynatrace shares gained 1.9% to $47.95 in pre-market trading. 
Via Benzinga
News headline image
Why PTC Therapeutics Could Be Victorious In Its Rare-Disease Battle Against BioMarin Pharmaceuticals ↗
The company is working on a treatment for PKU, a disorder that can lead to intellectual disabilities. 
Via Investor's Business Daily
News headline image
Why did Sarepta Therapeutics Stock Plummet?
SRPT stock fell 20% after the FDA changed course on their new DMD treatment approval. The stock remains strong with an encouraging outlook and a mod Buy rating. 
Via MarketBeat
News headline image
7 Nasdaq Stocks to Sell Before They Plunge in 2023 ↗
While loyalty may be a positive trait in most circumstances, when it comes to Nasdaq stocks to sell, you got to look out for number one. 
Via InvestorPlace
News headline image
Earnings Scheduled For April 27, 2023 ↗
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 ↗
 
Via Benzinga
News headline image
PTC Therapeutics's Return On Capital Employed Overview ↗
According to Benzinga Pro data, during Q3, PTC Therapeutics (NASDAQ:PTCT) posted sales of $217.13 million. Earnings were up 28.12%, but PTC Therapeutics still reported an overall loss of $109.31... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.